Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan-Mar;28(1):81-86.

Pediatric inflammatory bowel disease in Greece: 30-years experience of a single center

Affiliations

Pediatric inflammatory bowel disease in Greece: 30-years experience of a single center

Konstantina Dimakou et al. Ann Gastroenterol. 2015 Jan-Mar.

Abstract

Background: Significant advances have been made in the care of children with inflammatory bowel disease (IBD). We aimed to describe the trends during the last 3 decades in the clinical presentation, management, and outcome of pediatric IBD at a single center.

Methods: Medical records of children with IBD referred to a pediatric gastroenterology unit from January 1981 to December 2011 were reviewed retrospectively.

Results: A total of 483 children were diagnosed with IBD, with mean age at diagnosis of 9.6 years (range 6 months - 18 years). Ulcerative colitis (UC) was diagnosed in 267 (55.2%), Crohn's disease (CD) in 167 (34.5%), and IBD unclassified (IBDU) in 49 (10.1%). Children with UC and IBDU were younger than those with CD [mean age at diagnosis 9.2, 8.9, and 10.5 years respectively; P (UC vs. CD)<0.01 and P (IBDU vs. CD)=0.028]. Patients received 5-ASA (96.6%), steroids (77.0%), thiopurines (50.2%), biological agents (14%), and 10% underwent surgical intervention. The cohort was divided into three subgroups according to the date of diagnosis; Group A: 1981-1989, Group B: 1990-1999, and Group C: 2000-2011. During the last two decades a significant increase in CD (Group A 18.5%, Group B 23.8%, Group C 48.8%; P<0.01) compared with the first decade with parallel decrease in UC (Group A 79.6%, Group B 71.9%, Group C 33.2%; P<0.001) was observed.

Conclusions: Most children received 5-ASA, steroids, and immunomodulators. Patients with UC and IBDU were younger than those with CD. A significant increase in CD with parallel decrease in UC during the last decade was found.

Keywords: Crohn’s disease; Keywords Ιnflammatory bowel disease; children; treatment; ulcerative colitis; unclassified IBD.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
Mean diagnostic time lag over the study period Significant decrease in mean disease duration prior to diagnosis in CD patients during the last 2 decades (P=0.012)
Figure 2
Figure 2
Medication of the total IBD cohort and according to disease phenotype
Figure 3
Figure 3
Percentage of surgical intervention according to disease phenotype

References

    1. Satsangi J, Silverberg MS, Vermeire S, Colombel J-F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753. - PMC - PubMed
    1. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris Classification. InflammBowel Dis. 2011;17:1314–1321. - PubMed
    1. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol. 2001;36:2–15. - PubMed
    1. Paul T, Birnbaum A, Pal DK. Distinct phenotype of early childhood inflammatory bowel disease. J Clin Gastroenterol. 2006;40:583–586. - PubMed
    1. Griffiths AM. Specificities of inflammatory bowel disease in childhood. BestPract Res Clin Gastroenterol. 2004;18:509–523. - PubMed

LinkOut - more resources